N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-erythro-sphingosine
|
K021325-1mg
|
99% |
202850-01-9 |
1mg
|
¥ 5723.0
|
4~8周 |
科威 |
5H,6H,7H,8H-pyrido[3,4-d]pyrimidine hydrochloride
|
H635731-1g
|
≥97% |
192869-79-7 |
1g
|
¥ 2865.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 2-chloro-8-oxo-5,6-dihydropyrido[3,4-d]pyrimidine-7-carboxylate
|
T678256-5g
|
≥97% |
2665663-25-0 |
5g
|
¥ 31680.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 2-chloro-8-oxo-5,6-dihydropyrido[3,4-d]pyrimidine-7-carboxylate
|
T678256-100mg
|
≥97% |
2665663-25-0 |
100mg
|
¥ 2960.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 2-chloro-8-oxo-5,6-dihydropyrido[3,4-d]pyrimidine-7-carboxylate
|
T678256-1g
|
≥97% |
2665663-25-0 |
1g
|
¥ 10560.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 4-chloro-8-oxo-5,6-dihydropyrido[3,4-d]pyrimidine-7-carboxylate
|
T681978-500mg
|
≥97% |
N/A |
500mg
|
¥ 5328.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 4-chloro-8-oxo-5,6-dihydropyrido[3,4-d]pyrimidine-7-carboxylate
|
T681978-100mg
|
≥97% |
N/A |
100mg
|
¥ 1920.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 4-chloro-8-oxo-5,6-dihydropyrido[3,4-d]pyrimidine-7-carboxylate
|
T681978-1g
|
≥97% |
N/A |
1g
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 4-chloro-8-oxo-5,6-dihydropyrido[3,4-d]pyrimidine-7-carboxylate
|
T681978-250mg
|
≥97% |
N/A |
250mg
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 4-chloro-8-oxo-5,6-dihydropyrido[3,4-d]pyrimidine-7-carboxylate
|
T681978-25g
|
≥97% |
N/A |
25g
|
¥ 80000.9
|
期货,请咨询 |
阿拉丁 |
2-chloro-5H,7H-6λ⁶-thieno[3,4-d]pyrimidine-6,6-dione
|
C630407-250mg
|
≥97% |
1783678-42-1 |
250mg
|
¥ 2558.9
|
期货,请咨询 |
阿拉丁 |
2-methyl-5,6,7,8-tetrahydro-3H-pyrido[4,3-d]pyrimidin-4-one
|
M628378-250mg
|
≥97% |
134201-14-2 |
250mg
|
¥ 350.9
|
期货,请咨询 |
阿拉丁 |
2-methyl-5,6,7,8-tetrahydro-3H-pyrido[4,3-d]pyrimidin-4-one
|
M628378-100mg
|
≥97% |
134201-14-2 |
100mg
|
¥ 154.9
|
期货,请咨询 |
阿拉丁 |
2-chloro-5H,7H-6λ⁶-thieno[3,4-d]pyrimidine-6,6-dione
|
C630407-1g
|
≥97% |
1783678-42-1 |
1g
|
¥ 7682.9
|
期货,请咨询 |
阿拉丁 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-erythro-sphingosine
|
K021325-5mg
|
99% |
202850-01-9 |
5mg
|
¥ 24121.0
|
4~8周 |
科威 |
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine
|
K021618-5mg
|
99% |
94885-02-6 |
5mg
|
¥ 24121.0
|
4~8周 |
科威 |
7-bromo-Pyrido[3,2-d]pyrimidine-2,4(1H,3H)-dione
|
R093591-10mg
|
98% |
1215074-37-5 |
10mg
|
¥ 700.0
|
5~7个工作日 |
罗恩 |
7-bromo-Pyrido[3,2-d]pyrimidine-2,4(1H,3H)-dione
|
R093591-50mg
|
98% |
1215074-37-5 |
50mg
|
¥ 1260.0
|
5~7个工作日 |
罗恩 |
2-aMino-5,6,7,8-tetrahydropyrido[3,4-d]pyriMidin-4(3H)-one
|
R130971-25mg
|
95% |
1241674-80-5 |
25mg
|
¥ 1036.0
|
5~7个工作日 |
罗恩 |
2-chloro-5H,7H-6λ⁶-thieno[3,4-d]pyrimidine-6,6-dione
|
C630407-500mg
|
≥97% |
1783678-42-1 |
500mg
|
¥ 4268.9
|
期货,请咨询 |
阿拉丁 |
2-chloro-5H,7H-6λ⁶-thieno[3,4-d]pyrimidine-6,6-dione
|
C630407-100mg
|
≥97% |
1783678-42-1 |
100mg
|
¥ 1601.9
|
期货,请咨询 |
阿拉丁 |
5H,6H,7H,8H-pyrido[3,4-d]pyrimidine hydrochloride
|
H635731-10g
|
≥97% |
192869-79-7 |
10g
|
¥ 25864.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 4-chloro-8-oxo-5,6-dihydropyrido[3,4-d]pyrimidine-7-carboxylate
|
T681978-10g
|
≥97% |
N/A |
10g
|
¥ 40000.9
|
期货,请咨询 |
阿拉丁 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-erythro-sphingosine
|
R021325-5mg
|
99% |
202850-01-9 |
5mg
|
¥ 17304.0
|
5~7个工作日 |
罗恩 |